关键词：癫痫；脑部疾病；频谱症状；特发性癫痫
摘 要：Epilepsy is a spectrum of brain disorders varying from benign to severe, disabling, and lifethreatening symptoms. It is caused by various factors ranging from brain malformations and tumors to meningitis, high-risk pregnancies, and birth trauma. However, when the underlying cause of the disease is unidentified, as in the majority of the cases, it is known as idiopathic epilepsy. Epilepsy is characterized by repeated occurrence of generalized or focal seizures. An imbalance between the inhibitory and excitatory signals of the brain, leading to a sudden onset of excitation, results in seizures. Occurrence of two or more unprovoked seizures is an important criterion to diagnose a person as being epileptic.
目 录：

01. Executive Summary

02. List of Abbreviations

03. Scope of the Report

03.1 Market Overview

03.2 Product Offerings

04. Market Research Methodology

04.1 Market Research Process

04.2 Research Methodology

05. Introduction

06. Market Landscape

06.1 Market Overview

06.2 Market Size and Forecast

06.3 Five Forces Analysis

07. Market Segmentation by Generation of

Drugs

08. Geographical Segmentation

08.1 Epilepsy Market in Americas

08.1.1 Market Size and Forecast .

08.2 Epilepsy Market in EMEA Region

08.2.1 Market Size and Forecast

08.3 Epilepsy Market in APAC Region

08.3.1 Market Size and Forecast

09. Buying Criteria

10. Market Growth Drivers

11. Drivers and their Impact

12. Market Challenges

13. Impact of Drivers and Challenges

14. Market Trends

15. Trends and their Impact

16. Vendor Landscape

16.1 Competitive Scenario

16.1.1 Key News

16.1.2 Mergers and Acquisitions

16.2 Market Share Analysis 2013

16.2.1 Pfizer

16.2.2 UCB

16.2.3 GlaxoSmithKline

16.3 Other Prominent Vendors

17. Key Vendor Analysis

17.1 GlaxoSmithKline

17.1.1 Key Facts

17.1.2 Business Overview

17.1.3 Business Segmentation

17.1.4 Business Segmentation by Revenue 2012 and 2013

17.1.5 Sales by Geography

17.1.6 Pipeline Products

17.1.7 Business Strategy

17.1.8 Key Information

17.1.9 SWOT Analysis

17.2 Pfizer

17.2.1 Key Facts

17.2.2 Business Overview

17.2.3 Business Segmentation by Revenue 2013

17.2.4 Business Segmentation by Revenue 2012 and 2013

17.2.5 Geographical Segmentation by Revenue

17.2.6 Business Strategy

17.2.7 Key Developments

17.2.8 SWOT Analysis

17.3 UCB

17.3.1 Key Facts

17.3.2 Business Overview

17.3.3 Product Segmentation by Revenue 2013

17.3.4 Product Segmentation by Revenue 2012 and 2013

17.3.5 Geographical Segmentation by Revenue 2013

17.3.6 Business Strategy

17.3.7 Recent Developments

17.3.8 SWOT Analysis

18. Other Reports in this Series